Australia Microfluidics Market to Grow with a CAGR of 5.20% through 2030
Surge in research and development activities is
expected to drive the Australia Microfluidics Market growth in the forecast
period, 2026-2030.
According to TechSci Research report, “Australia Microfluidics
Market - By Region, Competition, Forecast
& Opportunities, 2030F”, the Australia Microfluidics Market stood at USD
377.25 Million in 2024 and is anticipated to grow with a CAGR of 5.20% through 2030.
Initiatives taken by government based on microfluidics has led to favorable
market conditions for the Australia Microfluidics Market. Several factors
contribute to the growth of various microfluidics products.
Leading research institutions, including universities
and national laboratories, are playing a pivotal role in advancing microfluidic
science. With growing emphasis on miniaturization, precision, and efficiency,
R&D initiatives are focused on enhancing device performance, reducing
sample volume, and integrating multiple analytical processes within compact,
user-friendly systems. These innovations are particularly significant for healthcare
applications, where there is increasing demand for rapid, accurate, and
minimally invasive diagnostic solutions.
One of the primary ways the government has contributed to the growth of the microfluidics sector is through sustained investment in medical research and development. Public funding agencies such as the National Health and Medical Research Council (NHMRC) and the Medical Research Future Fund (MRFF) have allocated substantial resources to support projects focused on microfluidic applications in diagnostics, therapeutics, and personalized medicine. These grants are often directed toward universities, research institutions, and startups working on lab-on-a-chip devices and point-of-care technologies.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Australia Microfluidics Market”
The Australia Microfluidics Market is segmented into material,
application, regional distribution, and company.
Based on Material, Silicon have emerged
as the dominating segment in the Australia Microfluidics Market in 2024. This
is due to its established role in high-precision applications, its
compatibility with semiconductor manufacturing processes, and its widespread
adoption in advanced research and medical diagnostics. Its dominance is closely
linked to the country's growing focus on miniaturized systems for healthcare,
biotechnology, and environmental monitoring fields where silicon-based
microfluidics offer unmatched performance and scalability.
Based on Region, Victoria have emerged as the fastest
growing region in the Australia Microfluidics Market in 2024. This is due to
its strong biomedical ecosystem, advanced research infrastructure, and
consistent government support. The state is home to a dense network of
hospitals, universities, research institutes, and medical technology companies,
particularly in Melbourne, which is recognized as one of the top life sciences
hubs in the Asia-Pacific region. This concentration of expertise and
institutions fosters close collaboration between academia and industry,
accelerating the development and commercialization of microfluidic
technologies.
Major companies operating in Australia Microfluidics
Market are:
- MTPConnect
- SCHOTT AG
- Microfluidics Biomedical Pty. Ltd.
- SDR Scientific Pty Ltd
- WHITE RABBIT SCIENTIFIC LIMITED
- Australian National Fabrication Facility
- Merck Pty. Ltd.
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“In Australia, leading universities and research
institutions such as the University of New South Wales (UNSW), the University
of Sydney, and CSIRO are at the forefront of developing nano-enabled
microfluidic systems. These platforms incorporate nanomaterials, including
quantum dots, gold nanoparticles, and nanowires, to improve signal
amplification and detection accuracy in biosensing applications. As a result,
diagnostic devices are becoming increasingly capable of identifying diseases at
earlier stages and from smaller sample volumes, aligning with the country’s
push toward faster and more accessible healthcare solutions”, said Mr. Karan
Chechi, Research Director of TechSci Research, a research-based management
consulting firm.
“Australia Microfluidics Market By Material (Glass, Silicon, Polymers, Others), By Application (In-vitro Diagnostics, Pharmaceutical & Life Science Research & Manufacturing, Therapeutics, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated
the future growth potential of Australia Microfluidics Market and provides
statistics & information on market size, structure, and future market growth.
The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Australia Microfluidics Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com